nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—osteoarthritis	0.434	0.586	CbGaD
Minocycline—MMP9—osteoarthritis	0.306	0.414	CbGaD
Minocycline—IL1B—synovial fluid—osteoarthritis	0.0124	0.126	CbGeAlD
Minocycline—IL1B—knee—osteoarthritis	0.0112	0.114	CbGeAlD
Minocycline—MMP9—synovial fluid—osteoarthritis	0.0104	0.105	CbGeAlD
Minocycline—IL1B—skeletal joint—osteoarthritis	0.00805	0.0815	CbGeAlD
Minocycline—MMP9—skeletal joint—osteoarthritis	0.00671	0.0679	CbGeAlD
Minocycline—IL1B—vertebral column—osteoarthritis	0.00639	0.0648	CbGeAlD
Minocycline—IL1B—leg—osteoarthritis	0.00615	0.0623	CbGeAlD
Minocycline—IL1B—synovial membrane of synovial joint—osteoarthritis	0.00611	0.0619	CbGeAlD
Minocycline—IL1B—forelimb—osteoarthritis	0.00611	0.0619	CbGeAlD
Minocycline—IL1B—hindlimb—osteoarthritis	0.00549	0.0557	CbGeAlD
Minocycline—IL1B—cartilage tissue—osteoarthritis	0.00541	0.0548	CbGeAlD
Minocycline—MMP9—hindlimb—osteoarthritis	0.00458	0.0464	CbGeAlD
Minocycline—MMP9—cartilage tissue—osteoarthritis	0.00451	0.0457	CbGeAlD
Minocycline—Doxycycline—MMP13—osteoarthritis	0.00268	0.591	CrCbGaD
Minocycline—Doxycycline—MMP1—osteoarthritis	0.00186	0.409	CrCbGaD
Minocycline—CASP1—tendon—osteoarthritis	0.0014	0.0142	CbGeAlD
Minocycline—CASP3—tendon—osteoarthritis	0.00116	0.0117	CbGeAlD
Minocycline—IL1B—tendon—osteoarthritis	0.000925	0.00937	CbGeAlD
Minocycline—VEGFA—tendon—osteoarthritis	0.00091	0.00922	CbGeAlD
Minocycline—MMP9—tendon—osteoarthritis	0.000771	0.00781	CbGeAlD
Minocycline—MMP9—TWEAK Signaling Pathway—TNF—osteoarthritis	0.000142	0.000906	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—COL9A1—osteoarthritis	0.000141	0.000902	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP13—osteoarthritis	0.000136	0.000869	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—CXCL8—osteoarthritis	0.000135	0.000865	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—IL1B—osteoarthritis	0.000134	0.000859	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—MMP2—osteoarthritis	0.000134	0.000859	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—LEP—osteoarthritis	0.000134	0.000857	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CAMK2B—osteoarthritis	0.000134	0.000857	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—PTGS2—osteoarthritis	0.000132	0.000846	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—TGFB1—osteoarthritis	0.000132	0.000843	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—BMP2—osteoarthritis	0.000131	0.000839	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—IGF1—osteoarthritis	0.000131	0.000839	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP3—osteoarthritis	0.000131	0.000838	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—CXCL8—osteoarthritis	0.000131	0.000834	CbGpPWpGaD
Minocycline—CYCS—Metabolism—FMOD—osteoarthritis	0.00013	0.000829	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TNF—osteoarthritis	0.000129	0.000823	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—MMP2—osteoarthritis	0.000129	0.000822	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—CXCL8—osteoarthritis	0.000128	0.00082	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000128	0.000817	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—IL6—osteoarthritis	0.000128	0.000816	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—CXCL8—osteoarthritis	0.000128	0.000815	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—osteoarthritis	0.000127	0.000809	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000125	0.000802	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	0.000125	0.000799	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TNF—osteoarthritis	0.000123	0.000787	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—TNF—osteoarthritis	0.000123	0.000787	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL1B—osteoarthritis	0.000123	0.000787	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.000123	0.000786	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—osteoarthritis	0.000122	0.000777	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—PTGS2—osteoarthritis	0.00012	0.000766	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—COL9A2—osteoarthritis	0.00012	0.000764	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TGFB1—osteoarthritis	0.000119	0.000763	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000119	0.00076	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—TGFB1—osteoarthritis	0.000118	0.000757	CbGpPWpGaD
Minocycline—VEGFA—VEGFR2 mediated cell proliferation—IL6—osteoarthritis	0.000118	0.000752	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—osteoarthritis	0.000117	0.00075	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.000117	0.000749	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TIMP1—osteoarthritis	0.000117	0.000748	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—TGFB1—osteoarthritis	0.000117	0.000746	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—CXCL8—osteoarthritis	0.000116	0.000743	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—MMP9—osteoarthritis	0.000116	0.000742	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—COL9A1—osteoarthritis	0.000116	0.000742	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000114	0.000731	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—IL6—osteoarthritis	0.000114	0.000731	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—MMP9—osteoarthritis	0.000114	0.00073	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.000114	0.000727	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—IL6—osteoarthritis	0.000112	0.000716	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP2—osteoarthritis	0.000112	0.000714	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TNF—osteoarthritis	0.000111	0.000713	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TNF—osteoarthritis	0.000111	0.000713	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—TNF—osteoarthritis	0.000109	0.000697	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000109	0.000694	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—TGFB1—osteoarthritis	0.000108	0.000693	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—TGFB1—osteoarthritis	0.000108	0.000688	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL1A—osteoarthritis	0.000107	0.000684	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CXCL8—osteoarthritis	0.000107	0.000682	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGES—osteoarthritis	0.000106	0.000676	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MMP9—osteoarthritis	0.000105	0.000672	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP1—osteoarthritis	0.000105	0.00067	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TGFB1—osteoarthritis	0.000104	0.000668	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—IL6—osteoarthritis	0.000104	0.000664	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—COL9A2—osteoarthritis	0.000104	0.000663	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.000103	0.000656	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL1B—osteoarthritis	0.000102	0.000654	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—TNF—osteoarthritis	0.000102	0.000654	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—CXCL8—osteoarthritis	0.000102	0.000651	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TGFB1—osteoarthritis	0.000101	0.000645	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—COL9A1—osteoarthritis	0.000101	0.000644	CbGpPWpGaD
Minocycline—CASP1—Immune System—CAMK2B—osteoarthritis	0.0001	0.000642	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTSK—osteoarthritis	0.0001	0.000642	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	9.88e-05	0.000631	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL1B—osteoarthritis	9.85e-05	0.00063	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TNF—osteoarthritis	9.75e-05	0.000623	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TGFB1—osteoarthritis	9.57e-05	0.000612	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—FN1—osteoarthritis	9.57e-05	0.000611	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	9.51e-05	0.000608	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—TGFB1—osteoarthritis	9.41e-05	0.000601	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	9.29e-05	0.000594	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—IL1B—osteoarthritis	9.28e-05	0.000593	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—PTGS2—osteoarthritis	9.19e-05	0.000587	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	9.12e-05	0.000583	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP3—osteoarthritis	9.1e-05	0.000582	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TNF—osteoarthritis	9.09e-05	0.000581	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	9e-05	0.000575	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TNF—osteoarthritis	8.94e-05	0.000571	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL1B—osteoarthritis	8.93e-05	0.000571	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—IL6—osteoarthritis	8.92e-05	0.00057	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CXCL8—osteoarthritis	8.91e-05	0.00057	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—osteoarthritis	8.9e-05	0.000569	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—IL6—osteoarthritis	8.8e-05	0.000562	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TGFB1—osteoarthritis	8.66e-05	0.000554	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—osteoarthritis	8.63e-05	0.000551	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL1B—osteoarthritis	8.55e-05	0.000546	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP9—osteoarthritis	8.39e-05	0.000536	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CXCL8—osteoarthritis	8.35e-05	0.000534	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—IL6—osteoarthritis	8.25e-05	0.000527	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP2—osteoarthritis	8.11e-05	0.000518	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—IL6—osteoarthritis	8.11e-05	0.000518	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—osteoarthritis	8.09e-05	0.000517	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CRP—osteoarthritis	8.03e-05	0.000513	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—FMOD—osteoarthritis	8e-05	0.000511	CbGpPWpGaD
Minocycline—CASP1—Immune System—HSPA5—osteoarthritis	7.99e-05	0.000511	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TGFB1—osteoarthritis	7.95e-05	0.000508	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—TGFB1—osteoarthritis	7.87e-05	0.000503	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MCF2L—osteoarthritis	7.8e-05	0.000499	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IHH—osteoarthritis	7.8e-05	0.000499	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1RN—osteoarthritis	7.77e-05	0.000497	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL6—osteoarthritis	7.67e-05	0.00049	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL6—osteoarthritis	7.6e-05	0.000486	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	7.56e-05	0.000483	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—FN1—osteoarthritis	7.5e-05	0.000479	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	7.5e-05	0.000479	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL1A—osteoarthritis	7.47e-05	0.000478	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTO1—osteoarthritis	7.45e-05	0.000476	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—osteoarthritis	7.42e-05	0.000474	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—IL6—osteoarthritis	7.33e-05	0.000469	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP1—osteoarthritis	7.28e-05	0.000465	CbGpPWpGaD
Minocycline—CYCS—Metabolism—BGN—osteoarthritis	7.22e-05	0.000461	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TGFB1—osteoarthritis	7.21e-05	0.000461	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL6—osteoarthritis	7.21e-05	0.000461	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—osteoarthritis	7.18e-05	0.000459	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IL6—osteoarthritis	7.17e-05	0.000458	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—osteoarthritis	7.15e-05	0.000457	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—osteoarthritis	7.09e-05	0.000453	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL6—osteoarthritis	7.01e-05	0.000448	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL6—osteoarthritis	6.96e-05	0.000445	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—osteoarthritis	6.74e-05	0.00043	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—FN1—osteoarthritis	6.65e-05	0.000425	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TGFB1—osteoarthritis	6.64e-05	0.000425	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—FN1—osteoarthritis	6.64e-05	0.000424	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—IGF1—osteoarthritis	6.57e-05	0.00042	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	6.54e-05	0.000418	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFB1—osteoarthritis	6.53e-05	0.000417	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL6—osteoarthritis	6.53e-05	0.000417	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGES—osteoarthritis	6.52e-05	0.000417	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	6.51e-05	0.000416	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—osteoarthritis	6.47e-05	0.000413	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HSPA5—osteoarthritis	6.34e-05	0.000405	CbGpPWpGaD
Minocycline—IL1B—Immune System—CAMK2B—osteoarthritis	6.27e-05	0.000401	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTSK—osteoarthritis	6.27e-05	0.000401	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—osteoarthritis	6.2e-05	0.000396	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	6.19e-05	0.000395	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—osteoarthritis	6.1e-05	0.00039	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP9—osteoarthritis	6.1e-05	0.00039	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	6.08e-05	0.000388	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TIMP1—osteoarthritis	6.04e-05	0.000386	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1B—osteoarthritis	5.94e-05	0.000379	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	5.82e-05	0.000372	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—osteoarthritis	5.77e-05	0.000369	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—COL9A2—osteoarthritis	5.73e-05	0.000366	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	5.73e-05	0.000366	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP2—osteoarthritis	5.63e-05	0.00036	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1A—osteoarthritis	5.6e-05	0.000358	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—COL9A1—osteoarthritis	5.56e-05	0.000355	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	5.43e-05	0.000347	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MCF2L—osteoarthritis	5.42e-05	0.000346	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IHH—osteoarthritis	5.42e-05	0.000346	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—osteoarthritis	5.25e-05	0.000335	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—osteoarthritis	5.23e-05	0.000334	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—osteoarthritis	5.22e-05	0.000334	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB1—osteoarthritis	5.02e-05	0.000321	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL6—osteoarthritis	5.01e-05	0.00032	CbGpPWpGaD
Minocycline—IL1B—Immune System—HSPA5—osteoarthritis	4.99e-05	0.000319	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—SMAD3—osteoarthritis	4.99e-05	0.000319	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL1RN—osteoarthritis	4.86e-05	0.00031	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MMP2—osteoarthritis	4.78e-05	0.000305	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IHH—osteoarthritis	4.7e-05	0.000301	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MCF2L—osteoarthritis	4.7e-05	0.000301	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	4.7e-05	0.0003	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—osteoarthritis	4.69e-05	0.0003	CbGpPWpGaD
Minocycline—CASP1—Immune System—CRP—osteoarthritis	4.68e-05	0.000299	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTO1—osteoarthritis	4.59e-05	0.000294	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—BGN—osteoarthritis	4.45e-05	0.000284	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—osteoarthritis	4.44e-05	0.000284	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—osteoarthritis	4.34e-05	0.000277	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—SMAD3—osteoarthritis	4.33e-05	0.000277	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—osteoarthritis	4.31e-05	0.000275	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—LEP—osteoarthritis	4.27e-05	0.000273	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP2—osteoarthritis	4.15e-05	0.000265	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CXCL8—osteoarthritis	4.06e-05	0.00026	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—COL9A2—osteoarthritis	3.98e-05	0.000254	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	3.92e-05	0.000251	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—COL9A1—osteoarthritis	3.86e-05	0.000247	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—BMP2—osteoarthritis	3.81e-05	0.000244	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MMP1—osteoarthritis	3.75e-05	0.00024	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—LEP—osteoarthritis	3.7e-05	0.000237	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	3.66e-05	0.000234	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—osteoarthritis	3.55e-05	0.000227	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL1A—osteoarthritis	3.5e-05	0.000223	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	3.49e-05	0.000223	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—osteoarthritis	3.49e-05	0.000223	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—osteoarthritis	3.48e-05	0.000222	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—COL9A2—osteoarthritis	3.45e-05	0.000221	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—FN1—osteoarthritis	3.43e-05	0.000219	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MMP2—osteoarthritis	3.41e-05	0.000218	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—COL9A1—osteoarthritis	3.35e-05	0.000214	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—osteoarthritis	3.27e-05	0.000209	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—osteoarthritis	3.12e-05	0.000199	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IGF1—osteoarthritis	3e-05	0.000192	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP2—osteoarthritis	2.96e-05	0.000189	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—osteoarthritis	2.93e-05	0.000187	CbGpPWpGaD
Minocycline—IL1B—Immune System—CRP—osteoarthritis	2.92e-05	0.000187	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—osteoarthritis	2.92e-05	0.000186	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.87e-05	0.000184	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BMP2—osteoarthritis	2.65e-05	0.000169	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP3—osteoarthritis	2.64e-05	0.000169	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SMAD3—osteoarthritis	2.39e-05	0.000153	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BMP2—osteoarthritis	2.3e-05	0.000147	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—osteoarthritis	2.28e-05	0.000146	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—osteoarthritis	2.23e-05	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—osteoarthritis	2.23e-05	0.000142	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—osteoarthritis	2.11e-05	0.000135	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—osteoarthritis	2.08e-05	0.000133	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LEP—osteoarthritis	2.04e-05	0.000131	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—osteoarthritis	1.97e-05	0.000126	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ESR1—osteoarthritis	1.95e-05	0.000125	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—osteoarthritis	1.94e-05	0.000124	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FN1—osteoarthritis	1.93e-05	0.000123	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—osteoarthritis	1.83e-05	0.000117	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MMP3—osteoarthritis	1.83e-05	0.000117	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—osteoarthritis	1.8e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—osteoarthritis	1.71e-05	0.000109	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—osteoarthritis	1.71e-05	0.000109	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1—osteoarthritis	1.69e-05	0.000108	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMAD3—osteoarthritis	1.66e-05	0.000106	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—osteoarthritis	1.59e-05	0.000102	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP3—osteoarthritis	1.59e-05	0.000102	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMAD3—osteoarthritis	1.44e-05	9.21e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LEP—osteoarthritis	1.42e-05	9.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—osteoarthritis	1.38e-05	8.83e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL8—osteoarthritis	1.36e-05	8.68e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ESR1—osteoarthritis	1.35e-05	8.66e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FN1—osteoarthritis	1.34e-05	8.55e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—osteoarthritis	1.28e-05	8.17e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LEP—osteoarthritis	1.23e-05	7.87e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—osteoarthritis	1.23e-05	7.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ESR1—osteoarthritis	1.18e-05	7.51e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1—osteoarthritis	1.17e-05	7.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FN1—osteoarthritis	1.16e-05	7.42e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—osteoarthritis	1.07e-05	6.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1—osteoarthritis	1.02e-05	6.5e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—osteoarthritis	1.01e-05	6.47e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL8—osteoarthritis	9.43e-06	6.02e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL8—osteoarthritis	8.18e-06	5.23e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—osteoarthritis	7.63e-06	4.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—osteoarthritis	7.4e-06	4.73e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—osteoarthritis	7.03e-06	4.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—osteoarthritis	6.1e-06	3.9e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—osteoarthritis	5.3e-06	3.38e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—osteoarthritis	4.6e-06	2.94e-05	CbGpPWpGaD
